丽珠医药8月26日斥资302.44万元回购7.26万股A股

Core Viewpoint - Lijun Pharmaceutical (01513) announced a share buyback plan, intending to repurchase 72,600 A-shares at a cost of 3.0244 million yuan by August 26, 2025 [1] Group 1 - The company plans to spend 3.0244 million yuan for the buyback [1] - The total number of shares to be repurchased is 72,600 [1]